Average Co-Inventor Count = 6.68
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbott Laboratories Corporation (12 from 4,177 patents)
2. Abbvie Inc. (8 from 822 patents)
3. Makoto, Aoyama (0 patent)
20 patents:
1. 10131657 - Bromodomain inhibitors
2. 10035800 - Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
3. 9957263 - Bromodomain inhibitors
4. 9561231 - Pyridinone and pyridazinone derivatives
5. 9321764 - Dihydro-pyrrolopyridinone inhibitors
6. 9296741 - Bromodomain inhibitors
7. 8436179 - Kinase inhibitor with improved solubility profile
8. 8435980 - Pyrrolopyridine inhibitors of kinases
9. 8293738 - Indazole inhibitors of kinase
10. 7468371 - Tricyclic pyrazole kinase inhibitors
11. 7129260 - Isoindolinone kinase inhibitors
12. 6294573 - Reverse hydroxamate inhibitors of matrix metalloproteinases
13. 5985911 - C-terminal ketone inhibitors of matrix metalloproteinases and TNF.alpha.
14. 5952320 - Macrocyclic inhibitors of matrix metalloproteinases and TNF.alpha.
15. 5665777 - Biphenyl hydroxamate inhibitors of matrix metalloproteinases